Clinical lung transplantation has developed over the past several years into a viable therapeutic option for many types of end-stage lung disease. Most patients benefiting from this therapy are adults with various types of end-stage emphysema, primary pulmonary hypertension, restrictive lung disease such as pulmonary fibrosis, and cystic fibrosis. Relatively few children are in need of lung transplantation, and because of a lack of donor organs, fewer still actually undergo this life-saving surgery. In 1995, nearly one-third of children on the lung transplant waiting list died while waiting a suitable organ. The investigators and others have already reported on the experimental and clinical application of """"""""reduced size"""""""" lung transplantation in which part of a more mature lung is transplanted into a smaller recipient in order to identify more donor organs for the pediatric population. Previous work on this project focused on examining the long-term functional results of reduced-size transplants and whether or not they were superior to size-matched immature whole lung transplants. In addition, the authors briefly began to identify the growth potential of reduced-size lung transplants, but only at a whole-organ level. It was found that a mature lobe transplanted into an immature recipient does have the ability to grow. The stimulus for and the cellular basis of this lung growth are unknown and are the focus of continued research. Studies will continue to be done in a porcine model of lung transplantation with which we are very familiar. New studies propose to identify factors present in the immature host environment which are responsible for lung growth and differentiation and how they may stimulate further growth of an already mature lobar transplant. Pneumocyte division and differentiation potential will also be examined. The time course and molecular modulation of normal pig lung growth and development will be studied to allow further interpretation of experimental results in the transplanted lungs. In addition, the effects of chronic rejection on growth potential of transplanted lungs will also be examined at the cellular and whole organ level. Identification of molecular modulators of normal lung development and their effects on cellular events of transplanted lungs will not only advance the field of lung transplantation, but will also form a basis for potential new treatments of other types of lung injury and provide a better understanding of lung growth following lung transplantation.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL048242-08
Application #
6183119
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Project Start
1993-01-01
Project End
2002-03-31
Budget Start
2000-04-01
Budget End
2001-03-31
Support Year
8
Fiscal Year
2000
Total Cost
$245,052
Indirect Cost
Name
University of Virginia
Department
Surgery
Type
Schools of Medicine
DUNS #
065391526
City
Charlottesville
State
VA
Country
United States
Zip Code
22904
Prorock, Alyson J; Hafezi-Moghadam, Ali; Laubach, Victor E et al. (2003) Vascular protection by estrogen in ischemia-reperfusion injury requires endothelial nitric oxide synthase. Am J Physiol Heart Circ Physiol 284:H133-40
Kaza, Aditya K; Kron, Irving L; Leuwerke, Shari M et al. (2002) Keratinocyte growth factor enhances post-pneumonectomy lung growth by alveolar proliferation. Circulation 106:I120-4
Kaza, Aditya K; Cope, Jeffrey T; Fiser, Steven M et al. (2002) Contrasting natures of lung growth after transplantation and lobectomy. J Thorac Cardiovasc Surg 123:288-94
Kaza, A K; Kron, I L; Long, S M et al. (2001) Epidermal growth factor receptor up-regulation is associated with lung growth after lobectomy. Ann Thorac Surg 72:380-5
Kaza, A K; Kron, I L; Kern, J A et al. (2001) Retinoic acid enhances lung growth after pneumonectomy. Ann Thorac Surg 71:1645-50
Kaza, A K; Laubach, V E; Kern, J A et al. (2000) Epidermal growth factor augments postpneumonectomy lung growth. J Thorac Cardiovasc Surg 120:916-21
Beum, P V; Singh, J; Burdick, M et al. (1999) Expression of core 2 beta-1,6-N-acetylglucosaminyltransferase in a human pancreatic cancer cell line results in altered expression of MUC1 tumor-associated epitopes. J Biol Chem 274:24641-8
King, R C; Laubach, V E; Kanithanon, R C et al. (1998) Preservation with 8-bromo-cyclic GMP improves pulmonary function after prolonged ischemia. Ann Thorac Surg 66:1732-8
Binns, O A; DeLima, N F; Buchanan, S A et al. (1997) Use of over-sized mature pulmonary lower lobe grafts results in superior pulmonary function. Ann Thorac Surg 64:307-12
King, R C; Binns, O A; Kanithanon, R C et al. (1997) Acellular low-potassium dextran preserves pulmonary function after 48 hours of ischemia. Ann Thorac Surg 64:795-800

Showing the most recent 10 out of 23 publications